Abstract:Background: Discrepancies in genetic alterations found in melanoma are conspicuous between different ethnic groups. With the approval of BRAF- and MEK-targeted inhibitors in China, it is necessary to further elucidate the landscape of gene mutation in Chinese melanoma patients.Methods: The frequency and distribution of BRAF, C-KIT, and NRAS mutations in 691 melanoma patients was determined, and the statistical significance of correlations between different gene mutations and clinicopathological features was analyzed.Results: Among a total of 691 patients, BRAF mutation was found in 166 patients (24.0%), and V600E was the prominent genetic alteration (145/166, 87.3%). Statistical analyses showed that younger patients (<60) had a higher BRAF mutation rate than older patients (≥60, P=0.000), and the frequency of BRAF mutation was more likely to be lower in patients with the following: melanoma located in an extremity (P=0.000), acral-lentiginous melanoma subtype (P=0.000), thinner melanoma thickness (P=0.047), and no ulceration (P=0.030). The frequency of NRAS mutation was 12.6% (38/302), and primarily involved codon 61 in exon 3 and codon 12 in exon 2. Mutation of C-KIT was detected in 65 patients (9.4%), and the most common site of mutations was L576 in exon 11 (29/65, 44.6%). Patients with NRAS or C-KIT mutation had higher Clark level (P=0.035 and 0.047, respectively) and were more likely to have melanoma located in an extremity (P=0.003 and 0.009, respectively) than those without such mutation. The concordance of gene mutations between paired primary and metastatic lesions was 89.6% (60/67), and visceral metastases showed the highest distribution of gene mutations versus primary melanomas (100.0%) compared with lymph nodes (90.9%) and cutaneous metastases (83.3%).Conclusions: In this large cohort of Chinese melanoma patients, the frequencies of BRAF and NRAS mutations were lower than those observed in Caucasian cohorts, but the clinicopathological features of BRAF, C-KIT, and NRAS mutation were consistent. Paired primary and metastatic lesions showed high concordance of gene mutations.

Analysis of Ckit and BRAF Mutations in 43 Chinese Patients with Ocular Melanomas

Aberrations of KIT, BRAF, NRAS, and PDGFRA in Chinese Melanoma Patients and Their Significance: Large, Scale Analysis of 644 Patients.

BRAF, C-KIT, and NRAS mutations correlated with different clinicopathological features: an analysis of 691 melanoma patients from a single center

C-KIT gene amplification in 262 Chinese melanoma patients

Data from Large-Scale Analysis of <i>kit</i> Aberrations in Chinese Patients with Melanoma

Integrative genomic analysis reveals cancer-associated mutations at the diagnosis of cancer in patients with ocular tumors

C-Kit Gene Mutation and CD117 Expression in Human Anorectal Melanomas.

Mutation scanning of BRAF, NRAS, KIT, and GNAQ/GNA11 in oral mucosal melanoma: a study of 57 cases

KRAS, BRAF and PIK3CA Mutations and the Loss of PTEN Expression in Chinese Patients with Colorectal Cancer.

Analysis of KIT Expression and Gene Mutation in Human Acral Melanoma: with a Comparison Between Primary Tumors and Corresponding Metastases/recurrences.

Prevalence of BRAF V600E Mutation in Chinese Melanoma Patients: Large Scale Analysis of BRAF and NRAS Mutations in a 432-Case Cohort.

C-kit-mutated Melanomas: the Chinese Experience

BRAF mutation in Chinese melanoma patients

Analysis of c-KIT expression and KIT gene mutation in human mucosal melanomas

The Clinical Significance of C-Kit Mutations in Metastatic Oral Mucosal Melanoma in China

Gene mutations and clinical prognosis of mucosal melanoma in different locations of head and neck

Clinicopathologic characteristics and outcomes of Chinese patients with non-small-cell lung cancer and BRAF mutation

The Mutation Profiles of Common Oncogenes Involved in Melanoma in Southern China

A Phase Ii Study of Imatinib for Advanced Melanoma Patients with Kit Aberrations

Analysis of gene mutations and clinical features in elderly patients with melanoma